2017
DOI: 10.1159/000475810
|View full text |Cite
|
Sign up to set email alerts
|

Cannabis Use among People Entering Drug Treatment in Europe: A Growing Phenomenon?

Abstract: This paper explores European and national trends in specialised drug treatment entry for cannabis-related problems. The analysis is based on data for the years 2003-2014 from 22 European countries. Between 2003 and 2014, the overall number and proportion of primary cannabis-related first-time entrants increased significantly. A joinpoint regression analysis indicates that the overall increase of cannabis treatment entries is continuous, although country-related differences are observed. Possible explanations f… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
33
0
1

Year Published

2018
2018
2020
2020

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 41 publications
(35 citation statements)
references
References 13 publications
(14 reference statements)
1
33
0
1
Order By: Relevance
“…The fact that young people in the "lax" perception group source information more from friends, people who have been in contact with drugs, and internet, whereas those in the "strict" perception group make significantly less use of those sources (turning to parents rather than friends, for example), tells us that a hefty 20% of our young people receive information via channels which probably confirm their "lax" perception of cannabis as a harmless drug and, in turn, are likely to become impervious to information from the mass media, talks in schools and colleges, etc. This concurs with Montanari et al [14], who affirmed that perception of cannabis-related risks influences requests for help. The challenge this study poses, therefore, is the need to take preventive action very early, not only transmitting information but also implementing initiatives which, taking into account the variables that influence early contact with cannabis, encourage people to heed such preventive instructions in real situations of risk [43].…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…The fact that young people in the "lax" perception group source information more from friends, people who have been in contact with drugs, and internet, whereas those in the "strict" perception group make significantly less use of those sources (turning to parents rather than friends, for example), tells us that a hefty 20% of our young people receive information via channels which probably confirm their "lax" perception of cannabis as a harmless drug and, in turn, are likely to become impervious to information from the mass media, talks in schools and colleges, etc. This concurs with Montanari et al [14], who affirmed that perception of cannabis-related risks influences requests for help. The challenge this study poses, therefore, is the need to take preventive action very early, not only transmitting information but also implementing initiatives which, taking into account the variables that influence early contact with cannabis, encourage people to heed such preventive instructions in real situations of risk [43].…”
Section: Discussionsupporting
confidence: 90%
“…In Europe, the figure stands at almost 20% [3]. Although knowledge of drugs and other health risks does not in itself predict preventive behavior or the avoidance of high-risk activity, we now know that risk perception regarding a substance-defined as "perception of the negative effects of drug consumption" [13] (p. 39)-deeply influences people's decisions about taking drugs and seeking help [14]. The risk levels of different drugs, as perceived by young people, influence their consumption: the riskier the consumption of a particular drug is seen to be, the less it is consumed, and vice versa [15][16][17].…”
Section: Introductionmentioning
confidence: 99%
“…Cannabis has become the primary reason for first‐time treatment entry across all illicit drugs world‐wide , with a 75% increase in Europe over the past 10 years . Possible explanations for this rise in treatment demands include increasing CUD prevalence, changes in risk perception, increasing cannabis potency, changes in referral practices and increasing availability and accessibility of treatment services . In Europe, 5–10% of daily and near‐daily users are currently in out‐patient treatment—indicating a large treatment gap .…”
Section: Clinical Representationmentioning
confidence: 99%
“…European countries providing eligible data 5 . While the explanation for this is unclear, it may be due to factors such as greater detection rates, improved pathways for referral, and changes in stigma towards mental health and treatment.…”
Section: With Rising Trends In 16 Of the 22mentioning
confidence: 99%